NASDAQ:CDIO Cardio Diagnostics (CDIO) Stock Price, News & Analysis $0.31 +0.09 (+40.58%) (As of 10/28/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends About Cardio Diagnostics Stock (NASDAQ:CDIO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cardio Diagnostics alerts:Sign Up Key Stats Today's Range$0.22▼$0.3350-Day Range$0.20▼$0.4552-Week Range$0.19▼$3.56Volume9.69 million shsAverage Volume929,009 shsMarket Capitalization$7.07 millionP/E RatioN/ADividend YieldN/APrice Target$2.00Consensus RatingBuy Company OverviewCardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.Read More… Unveiled: NVIDIA’s "Secret Royalty" Program (Ad)Did you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>> Cardio Diagnostics Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks76th Percentile Overall ScoreCDIO MarketRank™: Cardio Diagnostics scored higher than 76% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingCardio Diagnostics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageCardio Diagnostics has only been the subject of 1 research reports in the past 90 days.Read more about Cardio Diagnostics' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioCardio Diagnostics has a P/B Ratio of 2.23. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Cardio Diagnostics' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.65% of the float of Cardio Diagnostics has been sold short.Short Interest Ratio / Days to CoverCardio Diagnostics has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cardio Diagnostics has recently decreased by 63.57%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCardio Diagnostics does not currently pay a dividend.Dividend GrowthCardio Diagnostics does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted4.65% of the float of Cardio Diagnostics has been sold short.Short Interest Ratio / Days to CoverCardio Diagnostics has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cardio Diagnostics has recently decreased by 63.57%, indicating that investor sentiment is improving significantly. News and Social Media3.8 / 5News Sentiment0.92 News SentimentCardio Diagnostics has a news sentiment score of 0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.67 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Cardio Diagnostics this week, compared to 1 article on an average week.Search Interest5 people have searched for CDIO on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.MarketBeat Follows2 people have added Cardio Diagnostics to their MarketBeat watchlist in the last 30 days. Company Ownership3.3 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Cardio Diagnostics insiders have bought more of their company's stock than they have sold. Specifically, they have bought $29,882.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders30.00% of the stock of Cardio Diagnostics is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 8.06% of the stock of Cardio Diagnostics is held by institutions.Read more about Cardio Diagnostics' insider trading history. Receive CDIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardio Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address CDIO Stock News HeadlinesCaristo Diagnostics Wins Digital Health Award for CaRi-Heart® Cardiac Risk Prediction TechnologyOctober 23, 2024 | tmcnet.comCardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular TestsOctober 1, 2024 | businesswire.comEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.October 29, 2024 | Paradigm Press (Ad)Potential Catalyst Right Around The Corner? CMS To Announce Preliminary Medicare Payment For Cardio Diagnostics' Heart Disease TestsSeptember 18, 2024 | finance.yahoo.comCardio diagnostics CTO buys $19,999 in company stockSeptember 11, 2024 | uk.investing.comCardio diagnostics CEO buys $19,999 in company stockSeptember 11, 2024 | uk.investing.comCDIO Stock Earnings: Cardio Diagnostics Hldgs Beats EPS, Misses Revenue for Q2 2024August 12, 2024 | msn.comSandboxAQ Collaborates with Mayo Clinic on Novel Cardiac DiagnosticsAugust 8, 2024 | tmcnet.comSee More Headlines CDIO Stock Analysis - Frequently Asked Questions How have CDIO shares performed this year? Cardio Diagnostics' stock was trading at $2.49 on January 1st, 2024. Since then, CDIO stock has decreased by 87.5% and is now trading at $0.3118. View the best growth stocks for 2024 here. How were Cardio Diagnostics' earnings last quarter? Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) issued its quarterly earnings data on Monday, August, 12th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.13) by $0.07. The firm had revenue of $0.01 million for the quarter, compared to analysts' expectations of $0.13 million. Cardio Diagnostics had a negative trailing twelve-month return on equity of 312.97% and a negative net margin of 22,358.43%. How do I buy shares of Cardio Diagnostics? Shares of CDIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Cardio Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cardio Diagnostics investors own include Sangamo Therapeutics (SGMO), NVIDIA (NVDA), MSP Recovery (LIFW), MSP Recovery (LIFW), NuCana (NCNA), Recursion Pharmaceuticals (RXRX) and SoundHound AI (SOUN). Company Calendar Last Earnings8/12/2024Today10/29/2024Next Earnings (Estimated)11/11/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic substances Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:CDIO CUSIPN/A CIK1870144 Webcardiodiagnosticsinc.com Phone302-281-2147FaxN/AEmployees7Year FoundedN/APrice Target and Rating Average Stock Price Target$2.00 High Stock Price Target$2.00 Low Stock Price Target$2.00 Potential Upside/Downside+541.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,380,000.00 Net Margins-22,358.43% Pretax Margin-22,358.43% Return on Equity-312.97% Return on Assets-189.57% Debt Debt-to-Equity RatioN/A Current Ratio5.69 Quick Ratio5.69 Sales & Book Value Annual Sales$39,138.00 Price / Sales180.73 Cash FlowN/A Price / Cash FlowN/A Book Value$0.14 per share Price / Book2.23Miscellaneous Outstanding Shares22,686,000Free Float18,603,000Market Cap$7.07 million OptionableNot Optionable Beta4.79 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report This page (NASDAQ:CDIO) was last updated on 10/29/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredElon Musk Drops Stunning Bombshell?Elon Musk just dropped a BOMBSHELL that could send shockwaves throughout the tech industry… While deliverin...Paradigm Press | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardio Diagnostics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardio Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.